Australian Clinical Labs Limited (ASX:ACL)
Australia · Delayed Price · Currency is AUD 2.690
-0.030 (-1.10%)
At close: Dec 24, 2025
Australian Clinical Labs Market Cap
Australian Clinical Labs has a market cap or net worth of 513.51 million as of December 26, 2025. Its market cap has decreased by -25.42% in one year.
Market Cap
513.51M
Enterprise Value
782.39M
Revenue
741.27M
Ranking
n/a
PE Ratio
15.78
Stock Price
2.69
Market Cap Chart
Since May 14, 2021, Australian Clinical Labs's market cap has decreased from 690.27M to 513.51M, a decrease of -25.61%. That is a compound annual growth rate of -6.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 513.51M | -24.98% |
| Dec 31, 2024 | 684.50M | 18.13% |
| Dec 29, 2023 | 579.45M | -3.17% |
| Dec 30, 2022 | 598.41M | -52.18% |
| Dec 31, 2021 | 1.25B | 81.29% |
| May 14, 2021 | 690.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 82.72B |
| Pro Medicus | 23.58B |
| Cochlear | 17.13B |
| Sonic Healthcare | 11.15B |
| Ramsay Health Care | 8.09B |
| Ansell | 5.05B |
| Telix Pharmaceuticals | 4.03B |
| Mesoblast | 3.72B |